We're joining the global oncology community at #ESMO26 to advance progress for people living with cancer. Leveraging our expertise in immunology, we're advancing a clinical and pre-clinical pipeline of dual-masked #TCEs for multiple difficult-to-treat solid tumors. @myESMO https://t.co/6VsIuBoq6E